218 related articles for article (PubMed ID: 15652668)
1. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines.
Tudor D; Dubuquoy C; Gaboriau V; Lefèvre F; Charley B; Riffault S
Vaccine; 2005 Jan; 23(10):1258-64. PubMed ID: 15652668
[TBL] [Abstract][Full Text] [Related]
2. TLR9-/- and TLR9+/+ mice display similar immune responses to a DNA vaccine.
Babiuk S; Mookherjee N; Pontarollo R; Griebel P; van Drunen Littel-van den Hurk S; Hecker R; Babiuk L
Immunology; 2004 Sep; 113(1):114-20. PubMed ID: 15312142
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor signaling in anti-cancer immunity.
Okamoto M; Sato M
J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
[TBL] [Abstract][Full Text] [Related]
4. Priming of CD8+ T-cell responses after DNA immunization is impaired in TLR9- and MyD88-deficient mice.
Pavlenko M; Leder C; Moreno S; Levitsky V; Pisa P
Vaccine; 2007 Aug; 25(34):6341-7. PubMed ID: 17628235
[TBL] [Abstract][Full Text] [Related]
5. Oligodeoxynucleotides containing synthetic immunostimulatory motifs augment potent Th1 immune responses to HBsAg in mice.
Li Y; Kandimalla ER; Yu D; Agrawal S
Int Immunopharmacol; 2005 Jun; 5(6):981-91. PubMed ID: 15829414
[TBL] [Abstract][Full Text] [Related]
6. Immunostimulatory effects of plasmid DNA and synthetic oligodeoxynucleotides.
Zelenay S; Elías F; Fló J
Eur J Immunol; 2003 May; 33(5):1382-92. PubMed ID: 12731065
[TBL] [Abstract][Full Text] [Related]
7. Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.
Xu J; Xu W; Chen X; Zhao D; Wang Y
Vaccine; 2008 Aug; 26(35):4519-25. PubMed ID: 18598729
[TBL] [Abstract][Full Text] [Related]
8. Resiquimod is a modest adjuvant for HIV-1 gag-based genetic immunization in a mouse model.
Otero M; Calarota SA; Felber B; Laddy D; Pavlakis G; Boyer JD; Weiner DB
Vaccine; 2004 Apr; 22(13-14):1782-90. PubMed ID: 15068862
[TBL] [Abstract][Full Text] [Related]
9. Flt-3 ligand as adjuvant for DNA vaccination augments immune responses but does not skew TH1/TH2 polarization.
Westermann J; Nguyen-Hoai T; Mollweide A; Richter G; Schmetzer O; Kim HJ; Blankenstein T; Dörken B; Pezzutto A
Gene Ther; 2004 Jul; 11(13):1048-56. PubMed ID: 15085174
[TBL] [Abstract][Full Text] [Related]
10. Coimmunization with RANTES plasmid polarized Th1 immune response against hepatitis B virus envelope via recruitment of dendritic cells.
Ma K; Xu W; Shao X; Yanyue ; Hu L; Xu H; Yuan Z; Zheng X; Xiong S
Antiviral Res; 2007 Nov; 76(2):140-9. PubMed ID: 17655942
[TBL] [Abstract][Full Text] [Related]
11. The preferential induction of a Th1 immune response by DNA-based immunization is mediated by the immunostimulatory effect of plasmid DNA.
Leclerc C; Dériaud E; Rojas M; Whalen RG
Cell Immunol; 1997 Aug; 179(2):97-106. PubMed ID: 9268493
[TBL] [Abstract][Full Text] [Related]
12. Induction of antigen-specific Th1-biased immune responses by plasmid DNA in schistosoma-infected mice with a preexistent dominant Th2 immune profile.
Ayash-Rashkovsky M; Weisman Z; Zlotnikov S; Raz E; Bentwich Z; Borkow G
Biochem Biophys Res Commun; 2001 Apr; 282(5):1169-76. PubMed ID: 11302738
[TBL] [Abstract][Full Text] [Related]
13. Non-CpG-containing antisense 2'-methoxyethyl oligonucleotides activate a proinflammatory response independent of Toll-like receptor 9 or myeloid differentiation factor 88.
Senn JJ; Burel S; Henry SP
J Pharmacol Exp Ther; 2005 Sep; 314(3):972-9. PubMed ID: 15919763
[TBL] [Abstract][Full Text] [Related]
14. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines.
Ishii KJ; Kawagoe T; Koyama S; Matsui K; Kumar H; Kawai T; Uematsu S; Takeuchi O; Takeshita F; Coban C; Akira S
Nature; 2008 Feb; 451(7179):725-9. PubMed ID: 18256672
[TBL] [Abstract][Full Text] [Related]
15. Plasmids enriched with CpG motifs activate human peripheral blood mononuclear cells in vitro and enhance th-1 immune responses to hepatitis B surface antigen in mice.
Chen Z; Cao J; Liao X; Ke J; Zhu S; Zhao P; Qi Z
Viral Immunol; 2011 Jun; 24(3):199-209. PubMed ID: 21668361
[TBL] [Abstract][Full Text] [Related]
16. TLR9 signals after translocating from the ER to CpG DNA in the lysosome.
Latz E; Schoenemeyer A; Visintin A; Fitzgerald KA; Monks BG; Knetter CF; Lien E; Nilsen NJ; Espevik T; Golenbock DT
Nat Immunol; 2004 Feb; 5(2):190-8. PubMed ID: 14716310
[TBL] [Abstract][Full Text] [Related]
17. Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses.
Liang R; van den Hurk JV; Zheng C; Yu H; Pontarollo RA; Babiuk LA; van Drunen Littel-van den Hurk S
Vaccine; 2005 Nov; 23(45):5252-62. PubMed ID: 16154245
[TBL] [Abstract][Full Text] [Related]
18. Vaccination with plasmid DNA activates dendritic cells via Toll-like receptor 9 (TLR9) but functions in TLR9-deficient mice.
Spies B; Hochrein H; Vabulas M; Huster K; Busch DH; Schmitz F; Heit A; Wagner H
J Immunol; 2003 Dec; 171(11):5908-12. PubMed ID: 14634101
[TBL] [Abstract][Full Text] [Related]
19. Mouse strain-dependent differences in enhancement of immune responses by C3d.
Toapanta FR; Ross TM
Vaccine; 2004 Apr; 22(13-14):1773-81. PubMed ID: 15068861
[TBL] [Abstract][Full Text] [Related]
20. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
Zhang X; Yu C; Zhao J; Fu L; Yi S; Liu S; Yu T; Chen W
J Gene Med; 2007 Aug; 9(8):715-26. PubMed ID: 17595048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]